In the latest edition of Viewpoint, CRF President and CEO, Dr. Jack Lewin, covers the digital health revolution and its implications on cardiovascular medicine. In Part 1, Dr. Lewin provides an overview of the industry as well as some of the potential privacy and liability issues these new technologies will face. In Part 2, he discusses the use of digital technologies in clinical trials for recruiting and monitoring patients, as well as cardiovascular outcomes research. View Part 1 View Part 2